PIKA rabies vaccine

BIOLOGICAL2 trials

Sponsors

Yisheng Biopharma (Singapore) Pte. Ltd.

Conditions

Rabies

Phase 1

Safety and Efficacy of a PIKA Rabies Vaccine Containing the PIKA Adjuvant

CompletedNCT02657161

Yisheng Biopharma (Singapore) Pte. Ltd.Rabies

Start: 2015-02-28End: 2015-07-31Updated: 2016-01-15

Phase 2

Efficacy and Safety of a PIKA Rabies Vaccine Containing the PIKA Adjuvant With an Accelerated Regimen

CompletedNCT02956421

Yisheng Biopharma (Singapore) Pte. Ltd.Rabies

Start: 2016-02-29End: 2016-10-31Updated: 2016-11-08

Related Papers

A phase II randomized study to determine the safety and immunogenicity of the novel PIKA rabies vaccine containing the PIKA adjuvant using an accelerated regimen

Vaccine2017-11-2240 citations

An accelerated rabies vaccine schedule based on toll-like receptor 3 (TLR3) agonist PIKA adjuvant augments rabies virus specific antibody and T cell response in healthy adult volunteers.

2017-01-2225 citations